Skip to content
Search

Latest Stories

Majority of COVID-19 victims in India are aged over 60 years

THE COVID-19 pandemic has proved to be fatal for those aged above 60 years in India, data  showed.

Those above 60 years of age make up just 19% of coronavirus cases in the country, but the death rate is quite high at 63 per cent.


About 86 per cent of dead had conditions such as diabetes, hyperteension, heart and kidney diseases, health ministry data showed.

Te death toll due to the COVID-19 pandemic rose to 114 and the number of infections climbed to 4,421 in the country.

The active COVID-19 cases stood at 3,851, while 318 people were either cured or discharged and one had migrated, the ministry stated.

According to health ministry data, 30 per cent of those who died were 40-60 years old and only seven per cent were younger than 40.

In India, men are more vulnerable to the infection than women.

Out of the total cases 76 per cent are men. In total number of deaths men accounted for 73 per cent.

The highest number of confirmed cases are from Maharashtra (748), followed by Tamil Nadu at 571 and Delhi with 523 cases.

More For You

NHS cancer detection is stuck at 55 per cent. Here's why

Government targets 75 per cent early cancer detection by 2035, but Cancer Research UK says progress is falling short

Getty Images

NHS cancer detection is stuck at 55 per cent. Here's why

Highlights

  • One cancer diagnosis every 80 seconds in UK.
  • Early detection unchanged since 2013.
  • 107,000 patients wait over two months for treatment.
The NHS is not catching cancers any earlier than it did ten years ago. While 403,000 people now get a cancer diagnosis each year, the proportion caught at early stages stays around 55 per cent, barely changed from 54 per cent in 2013.

Cancer Research UK's latest report shows the detection system is not working well enough.

Michelle Mitchell, the charity's chief executive, called the findings "deeply worrying" and warned that "without urgent action, we won't see rates of improvements in cancer survival and outcomes that cancer patients deserve and expect."

Keep ReadingShow less